Trial Profile
Effects of Type 2 Diabetes on CYP450s Activities; Intersubject Variability in Drug Metabolism.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Bupropion (Primary) ; Caffeine (Primary) ; Chlorzoxazone (Primary) ; Dextromethorphan (Primary) ; Midazolam (Primary) ; Omeprazole (Primary) ; Tolbutamide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 22 Jul 2019 Status changed from recruiting to completed.
- 15 Feb 2018 Planned End Date changed from 1 Oct 2018 to 1 Oct 2019.
- 15 Feb 2018 Planned primary completion date changed from 1 Jan 2018 to 1 Jan 2019.